Viewing Study NCT05385861


Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2026-01-11 @ 9:23 AM
Study NCT ID: NCT05385861
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-08-15
First Post: 2022-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET
Sponsor: National Health Research Institutes, Taiwan
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module